TFG
NVO

Team Financial Group’s Novo Nordisk NVO Stock Holding History

Team Financial Group’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-100
Closed -$3.67K – 185
2026
Q1 		$3.67K Hold
100
– – ﹤0.01% 236
2025
Q4 		$5.09K Hold
100
– – ﹤0.01% 216
2025
Q3 		$5.55K Hold
100
– – ﹤0.01% 208
2025
Q2 		$6.9K Buy
+100
New +$6.8K ﹤0.01% 191

Other funds holding NVO

SRIM
Saratoga Research & Investment Management Saratoga, California $1.83B AUM 18.41% 1-Year Est. Return
SAM
Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return
GA
GuoLine Advisory Singapore $1.07B AUM 26.27% 1-Year Est. Return
QI
QV Investors Calgary, Alberta, Canada $1.3B AUM 31.14% 1-Year Est. Return
AA
ABC Arbitrage Paris, France $926M AUM 45.9% 1-Year Est. Return
OFA
Oak Family Advisors Chicago, Illinois $391M AUM 26.35% 1-Year Est. Return
PM
Penbrook Management New York $157M AUM 46.57% 1-Year Est. Return
PFS
Prospera Financial Services Dallas, Texas $6.89B AUM 37.41% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
AIP
ARS Investment Partners New York $2.29B AUM 113.95% 1-Year Est. Return

Team Financial Group's NVO Position: Q2 2026 in Review

Team Financial Group sold out of Novo Nordisk (NVO) in Q2 2026, closing a stake of 100 shares — an estimated $3.67K sold.

Team Financial Group first reported a position in NVO in Q2 2025 and held it in 4 quarters. The position peaked at $6.9K in Q2 2025. 387 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • Team Financial Group reported no remaining Novo Nordisk position as of Q2 2026 after selling out during the quarter.
  • Team Financial Group sold 100 Novo Nordisk shares in Q2 2026, an estimated $3.67K.
  • Team Financial Group first reported a position in Novo Nordisk in Q2 2025 and held it in 4 quarters.
  • Team Financial Group's Novo Nordisk position peaked at $6.9K in Q2 2025.
  • 387 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Team Financial Group's 13F filing for Q2 2026, filed 13 Jul 2026.